These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31564558)

  • 1. Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.
    Chen PH; Cai L; Huffman K; Yang C; Kim J; Faubert B; Boroughs L; Ko B; Sudderth J; McMillan EA; Girard L; Chen D; Peyton M; Shields MD; Yao B; Shames DS; Kim HS; Timmons B; Sekine I; Britt R; Weber S; Byers LA; Heymach JV; Chen J; White MA; Minna JD; Xiao G; DeBerardinis RJ
    Mol Cell; 2019 Dec; 76(5):838-851.e5. PubMed ID: 31564558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic approach to understand metabolic adaptation in non-small cell lung cancer.
    Martín-Bernabé A; Cortés R; Lehmann SG; Seve M; Cascante M; Bourgoin-Voillard S
    J Proteome Res; 2014 Nov; 13(11):4695-704. PubMed ID: 25029028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying Intermediary Metabolism and Lipogenesis in Cultured Mammalian Cells Using Stable Isotope Tracing and Mass Spectrometry.
    Cordes T; Metallo CM
    Methods Mol Biol; 2019; 1978():219-241. PubMed ID: 31119666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of metabolomics technologies toward cancer prognosis and therapy.
    Hoang G; Udupa S; Le A
    Int Rev Cell Mol Biol; 2019; 347():191-223. PubMed ID: 31451214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine reliance in cell metabolism.
    Yoo HC; Yu YC; Sung Y; Han JM
    Exp Mol Med; 2020 Sep; 52(9):1496-1516. PubMed ID: 32943735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancer.
    Meijer TWH; Peeters WJM; Dubois LJ; van Gisbergen MW; Biemans R; Venhuizen JH; Span PN; Bussink J
    Lung Cancer; 2018 Dec; 126():32-40. PubMed ID: 30527190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo.
    Brunelli L; Caiola E; Marabese M; Broggini M; Pastorelli R
    Sci Rep; 2016 Jun; 6():28398. PubMed ID: 27329432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontargeted elucidation of metabolic pathways using stable-isotope tracers and mass spectrometry.
    Hiller K; Metallo CM; Kelleher JK; Stephanopoulos G
    Anal Chem; 2010 Aug; 82(15):6621-8. PubMed ID: 20608743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming.
    Thiagarajan PS; Wu X; Zhang W; Shi I; Bagai R; Leahy P; Feng Y; Veigl M; Lindner D; Danielpour D; Yin L; Rosell R; Bivona TG; Zhang Z; Ma PC
    Oncotarget; 2016 Dec; 7(50):82013-82027. PubMed ID: 27852038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes.
    Balakrishnan K; Ganesan K
    Funct Integr Genomics; 2020 Nov; 20(6):813-824. PubMed ID: 32949316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines.
    Willmann L; Schlimpert M; Halbach S; Erbes T; Stickeler E; Kammerer B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():95-104. PubMed ID: 26218769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD147-mediated glucose metabolic regulation contributes to the predictive role of
    Li X; Fu Q; Zhu Y; Wang J; Liu J; Yu X; Xu W
    Mol Carcinog; 2019 Feb; 58(2):247-257. PubMed ID: 30320488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.
    Meijer TWH; Looijen-Salamon MG; Lok J; van den Heuvel M; Tops B; Kaanders JHAM; Span PN; Bussink J
    Thorac Cancer; 2019 Dec; 10(12):2289-2299. PubMed ID: 31668020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke.
    Babu N; Advani J; Solanki HS; Patel K; Jain A; Khan AA; Radhakrishnan A; Sahasrabuddhe NA; Mathur PP; Nair B; Keshava Prasad TS; Chang X; Sidransky D; Gowda H; Chatterjee A
    Microrna; 2018; 7(1):38-53. PubMed ID: 29299995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography-Mass Spectrometry.
    Mu Y; Zhou Y; Wang Y; Li W; Zhou L; Lu X; Gao P; Gao M; Zhao Y; Wang Q; Wang Y; Xu G
    J Proteome Res; 2019 May; 18(5):2175-2184. PubMed ID: 30892048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia.
    Wang Y; Bai C; Ruan Y; Liu M; Chu Q; Qiu L; Yang C; Li B
    Nat Commun; 2019 Jan; 10(1):201. PubMed ID: 30643150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
    Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
    J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
    O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.